Suppr超能文献

患有癌症及癌症康复患者的多种共病情况:系统评价方案。

Multimorbidity in patients living with and beyond cancer: protocol for a scoping review.

机构信息

Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London, London, UK

Centre for Primary Care, Wolfson Institute of Population Health, Queen Mary University of London, London, UK.

出版信息

BMJ Open. 2022 May 13;12(5):e057148. doi: 10.1136/bmjopen-2021-057148.

Abstract

INTRODUCTION

The number of people living with and beyond cancer is increasing rapidly. Many of them will experience ongoing physical or psychological sequelae as a result of their original cancer diagnosis or comorbidities arising from risk factors common to cancers and other long-term conditions. This poses the complex problem of managing cancer as a 'chronic' illness along with other existing comorbidities. This scoping review aims to map the literature available on multimorbidity in patients living with and beyond cancer, to explore, quantify and understand the impact of comorbid illnesses to inform work around cancer care in UK primary care settings.

METHODS AND ANALYSIS

This review will be guided by Joanna Briggs Institute Reviewer's manual for scoping reviews. A systematic literature search using Medical Subject Heading and text words related to cancer survivors and multimorbidity will be performed in MEDLINE, CINAHL, Embase and Web of Science, from 1990. Results will be described in a narrative style, reported in extraction tables and diagrams, and where appropriate in themes and text.

ETHICS AND DISSEMINATION

The scoping review will undertake secondary analysis of published literature; therefore, ethics committee approval is not required. Results will be disseminated through a peer-reviewed scientific journal and presented in relevant conferences. The scoping review will inform understanding of the burden of multimorbidity for cancer survivors, thus allow families, practitioners, clinicians and researchers to take the steps necessary to improve patient-centred care.

摘要

简介

患有癌症及癌症幸存者的人数正在迅速增加。许多人会因最初的癌症诊断或因癌症和其他长期疾病的共同风险因素而导致的合并症而持续出现身体或心理后遗症。这就提出了一个复杂的问题,即如何将癌症作为一种“慢性”疾病与其他现有合并症一起进行管理。本范围综述旨在绘制有关癌症幸存者合并症的文献图谱,以探索、量化和理解合并症对英国初级保健环境中癌症护理工作的影响。

方法和分析

本综述将遵循 Joanna Briggs 研究所审查员的范围审查手册。将使用与癌症幸存者和合并症相关的医学主题词和文本词,对 MEDLINE、CINAHL、Embase 和 Web of Science 中的文献进行系统的文献检索,检索时间从 1990 年开始。结果将以叙述的方式描述,报告在提取表和图表中,并在适当的情况下以主题和文本的形式呈现。

伦理和传播

范围综述将对已发表的文献进行二次分析;因此,不需要伦理委员会的批准。结果将通过同行评议的科学期刊发表,并在相关会议上展示。范围综述将告知人们对癌症幸存者合并症负担的理解,从而使家属、从业者、临床医生和研究人员能够采取必要的措施,改善以患者为中心的护理。

相似文献

1
Multimorbidity in patients living with and beyond cancer: protocol for a scoping review.
BMJ Open. 2022 May 13;12(5):e057148. doi: 10.1136/bmjopen-2021-057148.
5
Multimorbidity in children and youth: a scoping review protocol.
BMJ Open. 2018 May 24;8(5):e022413. doi: 10.1136/bmjopen-2018-022413.
6
Current definitions of advanced multimorbidity: a protocol for a scoping review.
BMJ Open. 2023 Nov 30;13(11):e076903. doi: 10.1136/bmjopen-2023-076903.
8
10
Exploring risk factors for comorbid depression in osteoarthritis: a scoping review protocol.
BMJ Open. 2025 Mar 3;15(3):e093353. doi: 10.1136/bmjopen-2024-093353.

引用本文的文献

1
Cryptogenic embolic stroke and cancer.
Front Neurol. 2025 Jun 13;16:1537779. doi: 10.3389/fneur.2025.1537779. eCollection 2025.
4
Multimorbidity in people living with and beyond cancer: a scoping review.
Am J Cancer Res. 2023 Sep 15;13(9):4346-4365. eCollection 2023.

本文引用的文献

1
Living with cancer and multimorbidity: A qualitative study of self-management experiences of older adults with cancer.
Eur J Oncol Nurs. 2021 Aug;53:101982. doi: 10.1016/j.ejon.2021.101982. Epub 2021 May 26.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Updated methodological guidance for the conduct of scoping reviews.
JBI Evid Synth. 2020 Oct;18(10):2119-2126. doi: 10.11124/JBIES-20-00167.
4
Living with cancer and multimorbidity: the role of primary care.
Curr Opin Support Palliat Care. 2019 Sep;13(3):213-219. doi: 10.1097/SPC.0000000000000454.
5
Multimorbidity in older adults living with and beyond cancer.
Curr Opin Support Palliat Care. 2019 Sep;13(3):220-224. doi: 10.1097/SPC.0000000000000439.
6
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
7
Defining and measuring multimorbidity: a systematic review of systematic reviews.
Eur J Public Health. 2019 Feb 1;29(1):182-189. doi: 10.1093/eurpub/cky098.
8
Changes in the prevalence of comorbidity in the Australian population with cancer, 2007-2014.
Cancer Epidemiol. 2018 Jun;54:56-62. doi: 10.1016/j.canep.2018.03.010. Epub 2018 Mar 26.
9
The impact of comorbidity on cancer and its treatment.
CA Cancer J Clin. 2016 Jul;66(4):337-50. doi: 10.3322/caac.21342. Epub 2016 Feb 17.
10
Trends in UK regional cancer mortality 1991-2007.
Br J Cancer. 2016 Feb 2;114(3):340-7. doi: 10.1038/bjc.2015.428. Epub 2016 Jan 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验